Laboratoires Euromedis specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The products include gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), diagnostic products, etc.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	14.28M 16.42M 13.29M 12.2M 23.04M 1.57B 23.4M 157M 61.48M 781M 61.68M 60.32M 2.62B	P/E 2024	-2.05x	P/E 2025	-84.9x
Enterprise Value	3.71M 4.27M 3.45M 3.17M 5.99M 408M 6.08M 40.72M 15.98M 203M 16.04M 15.68M 680M	EV / Sales 2024	0.57x	EV / Sales 2025	0.01x
Free-Float	34.87%	Yield 2024 *	-	Yield 2025	-

04-29	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
31/10/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
04/05/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/10/24	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
31/10/23	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/04/23	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/09/22	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2022	CI
29/04/22	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2021	CI
30/09/21	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2021	CI
08/07/21	Euromedis Groupe : Malaysia rubber glove body pleads for go-ahead to restart factories	RE
26/04/21	Global markets live: Philips, Crédit Suisse, Nestlé...
23/04/21	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2020	CI
23/09/20	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2020	CI

31/10/25	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER SEMESTRIEL 2025	PU
31/10/25	Laboratoires Euromedis : Euromedis - Communiqué semestriel 2025	PU
10/12/24	LABORATOIRES EUROMEDIS : Ajustement du contrat de liquidité	PU
26/04/24	Laboratoires Euromedis : Euromedis - Communiqué résultat 2023	PU
29/09/22	EUROMEDIS : Rapport Financier semestriel 2022	PU

06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
05-06	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER ANNUEL 2025
05-06	LABORATOIRES EUROMEDIS : Fin du contrat de liquidité
04-24	Laboratoires Euromedis : Communiqué résultat 2025
04-24	Laboratoires Euromedis : Résultats 2025 (7. Laboratoires Euromedis Communiqu e de presse r sultat 2025 v23.04.26)

Director	Title	Age	Since
Mathieu Roturier CHM	Chairman	49	25/11/2019
Joseph Asselin BRD	Director/Board Member	52	07/03/2017
Marion Tramier BRD	Director/Board Member	40	07/03/2017

EUROMEDIS Share Price Swiss Exchange

Stocks

OXEUMD

FR0000075343

Medical Equipment, Supplies & Distribution

Valuation: EUROMEDIS

Latest news : EUROMEDIS

Press Releases: EUROMEDIS

News in other languages: EUROMEDIS

Managers and Directors: EUROMEDIS

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROMEDIS	-.--%	-.--%	-	-	16.42M
ABBOTT LABORATORIES	+0.09%	+2.56%	-16.24%	-5.06%	183B
MEDTRONIC PLC	-0.37%	+2.62%	-5.37%	-2.70%	109B
CENCORA, INC.	-0.29%	+0.47%	+8.83%	+66.58%	60.57B
HOYA CORPORATION	+3.50%	+0.47%	+28.65%	+49.27%	51.8B
BECTON, DICKINSON AND COMPANY	+0.10%	+5.92%	-7.09%	-40.56%	45.64B
MEDLINE INC.	+0.41%	+1.37%	-	-	33.22B
DEXCOM, INC.	+11.95%	+16.65%	+3.32%	-33.00%	31.49B
WEST PHARMACEUTICAL SERVICES, INC.	+0.40%	+3.89%	+42.51%	-7.36%	24B
STERIS PLC	-1.22%	+6.69%	+0.84%	+1.26%	22.26B
Average	+1.46%	+4.86%	+6.93%	+3.56%	62.35B
Weighted average by Cap.	+0.92%	+3.49%	-1.36%	+4.41%

	2024	2025
Net sales	36.41M 41.89M 33.89M 31.12M 58.76M 4B 59.67M 399M 157M 1.99B 157M 154M 6.67B	41.06M 47.24M 38.22M 35.09M 66.27M 4.51B 67.29M 451M 177M 2.24B 177M 174M 7.53B
Net income	-6.11M -7.03M -5.69M -5.22M -9.86M -671M -10.01M -67.02M -26.3M -334M -26.39M -25.81M -1.12B	-132K -152K -123K -113K -213K -14.47M -216K -1.45M -567K -7.2M -569K -557K -24.16M
Net Debt	8.04M 9.25M 7.48M 6.87M 12.97M 883M 13.17M 88.18M 34.61M 439M 34.72M 33.96M 1.47B	-10.57M -12.15M -9.83M -9.03M -17.05M -1.16B -17.31M -116M -45.49M -578M -45.64M -44.64M -1.94B